Texas Hemp Lawsuit: Why Delta-9 and THCA Are Under Attack

At the heart of America’s evolving cannabis conversation sits a compound most people have heard of, but few fully understand: Delta-9 THC. It’s the molecule responsible for the “high” associated with cannabis, but today, it’s also at the center of legal battles, regulatory confusion, and a growing divide between science and policy.

Nowhere is that tension more visible than in Texas, where a new lawsuit is challenging sweeping hemp regulations that many argue could dismantle an entire industry. But to understand why hemp companies are fighting back and why Delta-9 is suddenly under scrutiny we need to start with the basics.

What Is Delta-9 THC?

Delta-9 tetrahydrocannabinol (Delta-9 THC) is the primary psychoactive compound found in cannabis. It interacts with the body’s endocannabinoid system, producing effects like euphoria, relaxation, and altered perception.

Here’s where things get complicated: Delta-9 exists in both cannabis and hemp. Chemically, they are the same plant species. The difference is not scientific, it’s legal, with the distinction coming from the 2018 Farm Bill, which federally legalized hemp by defining it as cannabis containing no more than 0.3% Delta-9 THC by dry weight. Anything above that threshold is legally considered marijuana.

So, in the eyes of the law:

• Hemp = ≤ 0.3% Delta-9 THC

• Marijuana = > 0.3% Delta-9 THC

But nature doesn’t follow legal definitions and that’s where the controversy begins.

Hemp vs. Cannabis: Same Plant, Different Rules

From a botanical standpoint, hemp and cannabis are nearly identical. Both can contain cannabinoids like CBD, Delta-9 THC, and THCA. The only real difference is how much Delta-9 THC is present before the plant is used.

This legal distinction created a booming hemp industry across the U.S., especially in states like Texas where traditional cannabis remains illegal. Hemp became a lifeline for farmers, entrepreneurs, and most importantly, patients seeking relief without access to medical marijuana programs.

But as the market expanded, so did innovation and eventually, exploitation.

The THCA Loophole Explained

To understand the current legal battle, we have to understand THCA.

Tetrahydrocannabinolic acid (THCA) is the raw, non-psychoactive precursor to Delta-9 THC. In its natural state, THCA does not produce a high. However, when exposed to heat, through smoking, vaping, or cooking, it undergoes a chemical process called decarboxylation and converts into Delta-9 THC. This means a hemp product can technically comply with federal law (by staying under 0.3% Delta-9 THC before use) while still containing high levels of THCA that become intoxicating when consumed.

Hemp producers quickly recognized this and many leaned into it.

High-THCA hemp flower began appearing across the country, marketed in ways that closely resembled cannabis products. In some cases, it was openly advertised as “legal weed” or something that would “get you high.”

This is where the line between innovation and irresponsibility began to blur.

When a Loophole Becomes a Liability

Instead of focusing solely on hemp’s wellness potential, such as CBD, minor cannabinoids, and even raw THCA’s therapeutic benefits, parts of the industry shifted toward mimicking the recreational cannabis market.

This resulted in:

• Products that looked, smelled, and functioned like marijuana

• Minimal regulatory oversight compared to licensed cannabis systems

• Messaging that invited scrutiny from lawmakers and regulators

In many ways, the hemp industry created its own vulnerability. By pushing the boundaries of legality and marketing psychoactive effects, it gave regulators a reason to step in.

And in Texas, they did.

The Texas Hemp Lawsuit: A Defining Moment

In April 2026, hemp businesses across Texas filed a lawsuit against the state, challenging new regulations implemented by the Texas Department of State Health Services (DSHS).

These rules dramatically changed how THC is calculated in hemp products. Instead of measuring only Delta-9 THC, as defined by federal law, DSHS introduced a “total THC” formula that includes THCA. This effectively reclassifies many federally compliant hemp products as illegal marijuana.

The consequences were immediate and severe:

• Smokable hemp products, including flower and concentrates, were banned from sale

• Over 9,000 registered businesses were impacted

• Products that made up two-thirds of the market were effectively eliminated

• Licensing fees skyrocketed, with some increasing from $250 to $10,000 annually

The lawsuit argues that these rules do not just regulate hemp; they rewrite the law entirely. Plaintiffs, including the Texas Hemp Business Council and multiple other companies, claim the state overstepped its authority, especially after lawmakers failed to pass stricter hemp regulations and Greg Abbott vetoed a previous bill on the issue.

At its core, the case asks a critical question: Can regulators redefine hemp beyond what the legislature and federal law already established?

Who Is Actually Being Hurt?

While this may seem like a battle between businesses and regulators, the real impact goes much deeper. Patients are among the first to feel the consequences. In states like Texas, where access to traditional cannabis is extremely limited, hemp products have filled a crucial gap. People rely on cannabinoids for relief from pain, anxiety, inflammation, and more.

Now, those same products are disappearing from shelves.

Additionally, the growing stigma around THCA is concerning. Despite being non-psychoactive in its raw form and having a wide range of potential therapeutic benefits, it is now being lumped in with intoxicating substances and treated as a problem to eliminate. This kind of policy reaction does not just target loopholes; it risks erasing access to beneficial compounds with proven benefits altogether.

Small businesses and farmers are also caught in the crossfire. Many operated within the law as it was written, only to find themselves suddenly non-compliant under a new interpretation.

And when legal access disappears, consumers do not stop, they turn elsewhere. Often, that means unregulated markets with fewer safety standards.

The Bigger Issue: Policy vs. Science

What’s unfolding in Texas reflects a broader national issue: laws struggling to keep up with science. THCA is not Delta-9 THC, hemp is not inherently marijuana, and cannabinoids are far more nuanced than current policy often allows. But instead of refining regulations to reflect that complexity, many states are responding with sweeping restrictions.

The result is a cycle where innovation creates gray areas, the industry pushes boundaries, and regulators then step in to overcorrect, while consumers and patients lose access.

Final Thoughts: A Call for Balance

Delta-9 THC is not the enemy, nor is hemp. The real issue lies in how both are being defined, marketed, and regulated. The hemp industry bears some responsibility for leaning too heavily into loopholes, but the response shouldn’t be to dismantle access altogether. What’s needed is thoughtful, science-based regulation and policies that protect consumers without punishing patients or small businesses.

At the end of the day, this is not just about Delta-9 or THCA. It’s about access, education, and ensuring that the people who rely on this plant are not the ones left behind.